CBT

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 955 M936 M923 M899 M849 M904 M 3.58 B Gross profit 235 M241 M244 M220 M211 M210 M 885 M Operating expenses 80 M79 M77 M94 M91 M92 M 354 M Selling/general/admin expenses 66 M64 M62 M68 M69 M67 M 266 M Research & development 14 M15 M15 M15 M13 M14 M 57 M Operating income 155 M162 M167 M137 M129 M129 M 562 M Non-Operating Income, Total 7 M8 M7 M-2 M7 M9 M 21 M Interest expense, net of interest capitalized 18 M19 M19 M20 M18 M18 M 75 M Non-Operating Income, excl. Interest Expenses -12 M-12 M-12 M-13 M-11 M-11 M -47 M Unusual income/expense 1 M1 M0-9 M02 M -7 M Pretax income 145 M154 M156 M117 M119 M122 M 514 M Equity in earnings 1 M3 M1 M2 M1 M2 M 6 M Taxes 41 M49 M43 M63 M37 M44 M 187 M Non-controlling/minority interest 11 M11 M12 M11 M9 M10 M 42 M After tax other income/expense -37 M-15 M-8 M-9 M-10 M4 M -23 M Net income before discontinued operations 93 M94 M101 M43 M73 M68 M 285 M Discontinued operations —————— — Net income 93 M94 M101 M43 M73 M68 M 285 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 92 M92 M100 M42 M72 M67 M 281 M Basic earnings per share (Basic EPS) 1.691.711.870.81.381.27 5.32 Diluted earnings per share (Diluted EPS) 1.671.691.860.81.371.27 5.3 Average basic shares outstanding 54.3 M54 M53.5 M53.7 M52.7 M52 M — Diluted shares outstanding 55 M54.4 M53.8 M54.2 M52.9 M52.2 M — EBITDA 192 M200 M206 M166 M161 M167 M 700 M EBIT 155 M162 M167 M126 M120 M118 M 531 M Cost of revenue 720 M695 M679 M679 M638 M694 M 2.69 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 37 M38 M39 M40 M41 M49 M 169 M